Literature DB >> 10604601

Anticonvulsant treatment of nerve agent seizures: anticholinergics versus diazepam in soman-intoxicated guinea pigs.

J H McDonough1, L D Zoeffel, J McMonagle, T L Copeland, C D Smith, T M Shih.   

Abstract

A total of eight anticholinergic drugs (aprophen, atropine, azaprophen, benactyzine, biperiden, procyclidine, scopolamine, trihexyphenidyl) were tested in parallel with diazepam for the ability to terminate seizure activity induced by the nerve agent soman. Guinea pigs, implanted with electrodes to record cortical electroencephalographic (EEG) activity, were pretreated with pyridostigmine Br (0.026 mg/kg, i.m.) and 30 min later challenged with 2 x LD50 soman (56 microg/kg, s.c.) followed 1 min later by treatment with atropine SO4 (2 mg/kg, i.m.) and pralidoxime chloride (2-PAM Cl; 25 mg/kg, i.m.). All guinea pigs developed sustained seizure activity following this treatment. Dose-effect curves were determined for the ability of each drug to terminate seizure activity when anticonvulsant treatment was given either 5 or 40 min after seizure onset. Body weight gain and recovery of behavioral performance of a previously trained one-way avoidance task were measured after exposure. With the exception of atropine, all anticholinergic drugs were effective at lower doses than diazepam in terminating seizures when given 5 min after seizure onset; benactyzine, procyclidine and aprophen terminated seizures most rapidly while scopolamine, trihexyphenidyl, biperiden, and diazepam were significantly slower. When given 40 min after seizure onset, diazepam was the most potent compound tested, followed by scopolamine, benactyzine and biperiden; atropine was not effective when tested 40 min after seizure onset. For diazepam, the time to terminate the seizure was the same whether it was given at the 5- or 40-min delay. In contrast, most anticholinergics were significantly slower in terminating seizure activity when

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10604601     DOI: 10.1016/s0920-1211(99)00060-1

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  22 in total

Review 1.  Midazolam as an anticonvulsant antidote for organophosphate intoxication--A pharmacotherapeutic appraisal.

Authors:  Sandesh D Reddy; Doodipala Samba Reddy
Journal:  Epilepsia       Date:  2015-05-29       Impact factor: 5.864

2.  Midazolam-Resistant Seizures and Brain Injury after Acute Intoxication of Diisopropylfluorophosphate, an Organophosphate Pesticide and Surrogate for Nerve Agents.

Authors:  Xin Wu; Ramkumar Kuruba; Doodipala Samba Reddy
Journal:  J Pharmacol Exp Ther       Date:  2018-08-16       Impact factor: 4.030

3.  Higher susceptibility of the ventral versus the dorsal hippocampus and the posteroventral versus anterodorsal amygdala to soman-induced neuropathology.

Authors:  James P Apland; Taiza H Figueiredo; Felicia Qashu; Vassiliki Aroniadou-Anderjaska; Adriana P Souza; Maria F M Braga
Journal:  Neurotoxicology       Date:  2010-06-08       Impact factor: 4.294

4.  Novel brain-penetrating oximes for reactivation of cholinesterase inhibited by sarin and VX surrogates.

Authors:  Janice E Chambers; Edward C Meek; Howard W Chambers
Journal:  Ann N Y Acad Sci       Date:  2016-05-06       Impact factor: 5.691

5.  Animal models that best reproduce the clinical manifestations of human intoxication with organophosphorus compounds.

Authors:  Edna F R Pereira; Yasco Aracava; Louis J DeTolla; E Jeffrey Beecham; G William Basinger; Edgar J Wakayama; Edson X Albuquerque
Journal:  J Pharmacol Exp Ther       Date:  2014-06-06       Impact factor: 4.030

Review 6.  Acute and long-term consequences of exposure to organophosphate nerve agents in humans.

Authors:  Taiza H Figueiredo; James P Apland; Maria F M Braga; Ann M Marini
Journal:  Epilepsia       Date:  2018-08-29       Impact factor: 5.864

7.  A new derivative of valproic acid amide possesses a broad-spectrum antiseizure profile and unique activity against status epilepticus and organophosphate neuronal damage.

Authors:  H Steve White; Anitha B Alex; Amanda Pollock; Naama Hen; Tawfeeq Shekh-Ahmad; Karen S Wilcox; John H McDonough; James P Stables; Dan Kaufmann; Boris Yagen; Meir Bialer
Journal:  Epilepsia       Date:  2011-12-09       Impact factor: 5.864

Review 8.  Unequal efficacy of pyridinium oximes in acute organophosphate poisoning.

Authors:  Biljana Antonijevic; Milos P Stojiljkovic
Journal:  Clin Med Res       Date:  2007-03

9.  Soman induces ictogenesis in the amygdala and interictal activity in the hippocampus that are blocked by a GluR5 kainate receptor antagonist in vitro.

Authors:  J P Apland; V Aroniadou-Anderjaska; M F M Braga
Journal:  Neuroscience       Date:  2008-12-14       Impact factor: 3.590

10.  A comparison of the neuroprotective efficacy of newly developed oximes (K117, K127) and currently available oxime (obidoxime) in tabun-poisoned rats.

Authors:  Jiri Kassa; Jana Zdarova Karasova; Kamil Musilek; Kamil Kuca; And Young-Sik Jung
Journal:  Toxicol Mech Methods       Date:  2009-03       Impact factor: 2.987

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.